Also trades as: CO (NYSE) · $vol 1M
CORBF OTC
Global Cord Blood Corporation
1W: +0.1%
1M: +0.1%
3M: +0.1%
YTD: +0.1%
1Y: -4.9%
3Y: -20.8%
5Y: -80.8%
$0.95
+0.00 (+0.00%)
Weekly Expected Move ±0.2%
$1
$1
$1
$1
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$614M
-2.7% ▼
5Y CAGR: -0.8%
Capital Expenditures
$20M
+5.3% ▲
5Y CAGR: -4.3%
Free Cash Flow
$594M
-2.6% ▼
5Y CAGR: -0.6%
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$585M
-2.9% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $241M | $295M | $478M | $516M | $509M |
| Depreciation & Amort. | $51M | $52M | $49M | $49M | $48M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $420M | $363M | $64M | $58M | -$4M |
| Other Non-Cash Items | $33M | $96M | $40M | $14M | $57M |
| Operating Cash Flow | $819M | $792M | $624M | $631M | $614M |
| — Investing Activities — | |||||
| Capital Expenditures | -$67M | -$31M | -$24M | -$21M | -$20M |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | -$340M | $0 | $0 |
| Investment Sales | $217K | $0 | $210M | $0 | $0 |
| Other Investing | $372K | $479K | $8M | $785K | $154K |
| Investing Cash Flow | -$66M | -$30M | -$146M | -$20M | -$20M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$2M | -$21M | -$4M | -$6M | -$8M |
| Financing Cash Flow | -$2M | -$21M | -$4M | -$6M | -$8M |
| Net Change in Cash | $740M | $747M | $476M | $602M | $585M |
| Cash End of Period | $4.3B | $5.0B | $5.5B | $6.1B | $6.7B |
| Free Cash Flow | $752M | $761M | $600M | $610M | $594M |